European patent issued to Bavarian Nordic A/S on MVA-BN®
On 28 December, 2005, the European Patent Organisation (EPO) issued a patent to Bavarian Nordic that protects the company’s MVA-BN® technology.
The patent belongs to the same patent family as the earlier-issued US patents (USP 6,791,893 and USP 6,913,752) and covers the MVA-BN® virus and derivatives hereof with the same biological characteristics and safety profile as well as recombinant viruses hereof. The patent gives Bavarian Nordic the sole right to produce, market and sell MVA-BN®, and derivatives hereof with the same biological characteristics and safety profile as well as recombinant viruses hereof in Europe.
